Cargando…
Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
We previously found that leflunomide combined with low-dose prednisone rapidly improved the clinical symptoms of myasthenia gravis (MG), but we had not investigated the mechanism of this phenomenon. This study documents the effect of leflunomide combined with low-dose prednisone on pro-inflammatory...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508276/ https://www.ncbi.nlm.nih.gov/pubmed/36164461 http://dx.doi.org/10.3389/fneur.2022.961628 |
_version_ | 1784796987999125504 |
---|---|
author | Huang, Xin Ran, Hao Li, Yingkai Ma, Qian Ou, Changyi Qiu, Li Feng, Huiyu Liu, Weibin |
author_facet | Huang, Xin Ran, Hao Li, Yingkai Ma, Qian Ou, Changyi Qiu, Li Feng, Huiyu Liu, Weibin |
author_sort | Huang, Xin |
collection | PubMed |
description | We previously found that leflunomide combined with low-dose prednisone rapidly improved the clinical symptoms of myasthenia gravis (MG), but we had not investigated the mechanism of this phenomenon. This study documents the effect of leflunomide combined with low-dose prednisone on pro-inflammatory T cells in MG patients. We compared 32 treated MG patients with 18 controls. We collected peripheral blood before treatment and 4, 8, and 12 weeks after treatment. We extracted peripheral blood mononuclear cells (PBMCs) and stimulated them with phorbol 12-myristate 13-acetate (PMA) + ionomycin and quantified IFN-γ, IL-4, IL-17, and IL-9 secretion through ELISA. We quantified T helper (Th) cells Th1 (CD3+CD4+IFN-γ+), Th2 (CD3+CD4+IL-4+), Th17 (CD3+CD4+IL-17A+) and Th9 (CD3+CD4+IL-9+) among PBMCs. The treatment significantly reduced IL-17 and IL-9 secretion in peripheral blood but did not affect IFN-γ levels. Significant decreases in IL-17 and IL-9 appeared at week 12, and the trend of change was similar to that of the MG composite score. Flow cytometry indicated that leflunomide combined with low-dose prednisone significantly reduced the frequency of Th1 and Th17 cells. These findings demonstrate the potential of this treatment as an alternative immunosuppressive therapy for MG. |
format | Online Article Text |
id | pubmed-9508276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95082762022-09-25 Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients Huang, Xin Ran, Hao Li, Yingkai Ma, Qian Ou, Changyi Qiu, Li Feng, Huiyu Liu, Weibin Front Neurol Neurology We previously found that leflunomide combined with low-dose prednisone rapidly improved the clinical symptoms of myasthenia gravis (MG), but we had not investigated the mechanism of this phenomenon. This study documents the effect of leflunomide combined with low-dose prednisone on pro-inflammatory T cells in MG patients. We compared 32 treated MG patients with 18 controls. We collected peripheral blood before treatment and 4, 8, and 12 weeks after treatment. We extracted peripheral blood mononuclear cells (PBMCs) and stimulated them with phorbol 12-myristate 13-acetate (PMA) + ionomycin and quantified IFN-γ, IL-4, IL-17, and IL-9 secretion through ELISA. We quantified T helper (Th) cells Th1 (CD3+CD4+IFN-γ+), Th2 (CD3+CD4+IL-4+), Th17 (CD3+CD4+IL-17A+) and Th9 (CD3+CD4+IL-9+) among PBMCs. The treatment significantly reduced IL-17 and IL-9 secretion in peripheral blood but did not affect IFN-γ levels. Significant decreases in IL-17 and IL-9 appeared at week 12, and the trend of change was similar to that of the MG composite score. Flow cytometry indicated that leflunomide combined with low-dose prednisone significantly reduced the frequency of Th1 and Th17 cells. These findings demonstrate the potential of this treatment as an alternative immunosuppressive therapy for MG. Frontiers Media S.A. 2022-09-09 /pmc/articles/PMC9508276/ /pubmed/36164461 http://dx.doi.org/10.3389/fneur.2022.961628 Text en Copyright © 2022 Huang, Ran, Li, Ma, Ou, Qiu, Feng and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Huang, Xin Ran, Hao Li, Yingkai Ma, Qian Ou, Changyi Qiu, Li Feng, Huiyu Liu, Weibin Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients |
title | Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients |
title_full | Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients |
title_fullStr | Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients |
title_full_unstemmed | Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients |
title_short | Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients |
title_sort | leflunomide combined with low-dose prednisone inhibits proinflammatory t cells responses in myasthenia gravis patients |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508276/ https://www.ncbi.nlm.nih.gov/pubmed/36164461 http://dx.doi.org/10.3389/fneur.2022.961628 |
work_keys_str_mv | AT huangxin leflunomidecombinedwithlowdoseprednisoneinhibitsproinflammatorytcellsresponsesinmyastheniagravispatients AT ranhao leflunomidecombinedwithlowdoseprednisoneinhibitsproinflammatorytcellsresponsesinmyastheniagravispatients AT liyingkai leflunomidecombinedwithlowdoseprednisoneinhibitsproinflammatorytcellsresponsesinmyastheniagravispatients AT maqian leflunomidecombinedwithlowdoseprednisoneinhibitsproinflammatorytcellsresponsesinmyastheniagravispatients AT ouchangyi leflunomidecombinedwithlowdoseprednisoneinhibitsproinflammatorytcellsresponsesinmyastheniagravispatients AT qiuli leflunomidecombinedwithlowdoseprednisoneinhibitsproinflammatorytcellsresponsesinmyastheniagravispatients AT fenghuiyu leflunomidecombinedwithlowdoseprednisoneinhibitsproinflammatorytcellsresponsesinmyastheniagravispatients AT liuweibin leflunomidecombinedwithlowdoseprednisoneinhibitsproinflammatorytcellsresponsesinmyastheniagravispatients |